Global innovative medical firms pick KL as regional hub


People power: Roach says AstraZeneca invests substantially to upskill and develop its people.

GLOBAL medical technology and pharmaceutical firms are turning to Malaysia as their investment destination, as they chart their mid-to-long term growth strategy across the region.

For biopharmaceutical company AstraZeneca, the focus going forward will be on achieving growth through a science-led innovation strategy, its country president and managing director Dr Sanjeev Panchal said.

Article type: metered
User Type: anonymous web
User Status:
Campaign ID: 31
Cxense type: NA
User access status: 3
Subscribe now to our Premium Plan for an ad-free and unlimited reading experience!
   

Next In Business News

Tenaga plans US$1bil IPO for power business, sources say
Construction industry players appeal government to review industry regulations
Ringgit ends higher against US dollar for fourth consecutive day
Tan Chong gets 4-year extension for its solar project PPA
Heineken Malaysia reports three-fold increase in 2Q net profit
Tengku Zafrul: Google Cloud will enable Malaysia to move forward digitally
Bursa Malaysia advances on better-than-expected GDP
Core inflation forecast at upper range of 2% to 3% in 2022
Indonesia rupiah hits two-month high among mixed Asian FX
Asian stocks fall on nagging Fed rate hike worries

Others Also Read